Do you want to read an article? Please log in or register.
Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure
Bronchi
RECOMMENDED
Related content
RECOMMENDED
Pneumonia
Patient Reported Outcome Measures in the recovery of adults hospitalised with community-acquired pneumonia: a systematic review
Eur Respir J.
Pick HJ, Bolton CE, Lim WS, McKeever TM
doi: 10.1183/13993003.
RECOMMENDED
Interstitial Lung DiseasePulmonary Fibrosis
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev
Kalluri M, Luppi F, Vancheri A, Vancheri C, Balestro E, Varone F, Mogulkoc N, Cacopardo G, Bargagli E, Renzoni E, Torrisi S, Calvello M, Libra A, Pavone M, Bonella F, Cottin V, Valenzuela C, Wijsenbeek M, Bendstrup E, 3rd International Summit for ILD (ISILD), Erice collaborators listed below.
doi: 10.1183/16000617.0026-2021
COPD
Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease (PREM-C9)
Thorax.
Hodson M, Roberts CM, Andrew S, Graham L, Jones PW, Yorke J
doi: 10.1136/thoraxjnl-2018-211732.
RECOMMENDED
Bronchi
Measuring airway clearance outcomes in bronchiectasis: a review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir Rev.
Franks LJ, Walsh JR, Hall K, Morris NR
doi: 10.1183/16000617.0161-2019.
RECOMMENDED
COPD
Minimal clinically important differences for patient-reported outcome measures of fatigue in patients with COPD after pulmonary rehabilitation
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Rebelo P, Oliveira A, Andrade L, Valente C, Marques A
doi: 10.1016/j.chest.2020.02.045.
RECOMMENDED
Lung Cancer
Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study
★ 1
Recommended by
Prof. Dr Stephan Bodis, Faculty Member
★ 2
Recommended by
Alexander Meisel, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Oncol.
Hui R, Özgüroğlu M, Villegas A, Daniel D, Vicente D, Murakami S, Yokoi T, Chiappori A, Lee KH, de Wit M, Cho BC, Gray JE, Rydén A, Viviers L, Poole L, Zhang Y, Dennis PA, Antonia SJ
doi: 10.1016/S1470-2045(19)30519-4.
RECOMMENDED
Pulmonary Fibrosis
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros
McLeod C, Wood J, Schultz A, Norman R, Smith S, Blyth CC, Webb S, Smyth AR, Snelling TL
doi: 10.1016/j.jcf.2020.08.015
RECOMMENDED
Pulmonary Fibrosis
Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Res.
Kreuter M, Wuyts WA, Wijsenbeek M, Bajwah S, Maher TM, Stowasser S, Male N, Stansen W, Schoof N, Orsatti L, Swigris J
doi: 10.1186/s12931-020-1298-1.
RECOMMENDED
Sleep Apnea
Responsiveness of Patient Reported Outcomes to Treatment among Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnea
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Chest.
Donovan LM, Yu L, Bertisch SM, Buysse DJ, Rueschman M, Patel SR
doi: 10.1016/j.chest.2019.11.011.